Corcept Therapeutics Inc SEC filings CORT

Corcept Therapeutics Inc has 1,001 filings in SEC EDGAR's recent list, going back to Mar 10, 2016. Its latest annual report, Form 10-K, was filed on Feb 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Corcept Therapeutics Inc SEC filings
Form Description Filed Period
4 Insider transaction Nov 4, 2026 Nov 2, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Nov 3, 2026 Nov 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
4 Insider transaction Oct 16, 2026 Oct 15, 2026
4 Insider transaction Oct 5, 2026 Oct 2, 2026
4 Insider transaction Oct 5, 2026 Oct 1, 2026
4 Insider transaction Oct 5, 2026 Oct 1, 2026
4 Insider transaction Oct 5, 2026 Oct 1, 2026
3 Initial insider ownership Oct 5, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
4 Insider transaction Sep 28, 2026 Sep 24, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 23, 2026 Sep 22, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 18, 2026 Sep 17, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 16, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 15, 2026 —
144 Notice of proposed sale Sep 14, 2026 —
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
3 Initial insider ownership Sep 3, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 2, 2026 —
4 Insider transaction Aug 28, 2026 Aug 26, 2026
4 Insider transaction Aug 27, 2026 Aug 25, 2026
144 Notice of proposed sale Aug 26, 2026 —
144 Notice of proposed sale Aug 25, 2026 —
4 Insider transaction Aug 20, 2026 Aug 18, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
4 Insider transaction Aug 18, 2026 Aug 14, 2026
4 Insider transaction Aug 18, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 18, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
4 Insider transaction Aug 14, 2026 Aug 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 13, 2026 —
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 12, 2026 Aug 10, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 4, 2026 —
4 Insider transaction Aug 3, 2026 Jul 30, 2026
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Jul 30, 2026 —
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Jul 29, 2026 Jul 29, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 8, 2026 May 27, 2026
4 Insider transaction Jul 8, 2026 Jul 7, 2026
144 Notice of proposed sale Jul 7, 2026 —
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 18, 2026 Jun 17, 2026
8-K Current report
Other events
Jun 17, 2026 Jun 17, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 16, 2026 —
144 Notice of proposed sale Jun 16, 2026 —
4 Insider transaction Jun 4, 2026 Jun 2, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
8-K Current report
Other events
Jun 3, 2026 May 19, 2026
4 Insider transaction Jun 2, 2026 May 29, 2026
144 Notice of proposed sale Jun 2, 2026 —
144 Notice of proposed sale Jun 1, 2026 —
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
4 Insider transaction May 29, 2026 May 27, 2026
S-8 Employee stock plan registration May 29, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
May 28, 2026 May 21, 2026
144 Notice of proposed sale May 27, 2026 —
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
4 Insider transaction May 26, 2026 May 21, 2026
144 Notice of proposed sale May 20, 2026 —
4 Insider transaction May 15, 2026 May 13, 2026
4 Insider transaction May 7, 2026 May 5, 2026
4 Insider transaction May 5, 2026 May 1, 2026
144 Notice of proposed sale May 5, 2026 —
144 Notice of proposed sale May 1, 2026 —
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Apr 30, 2026 Apr 30, 2026
4 Insider transaction Apr 24, 2026 Apr 22, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 21, 2026 —
DEF 14A Proxy statement Apr 17, 2026 Apr 17, 2026
4 Insider transaction Apr 8, 2026 Apr 7, 2026
4 Insider transaction Apr 8, 2026 Apr 6, 2026
144 Notice of proposed sale Apr 7, 2026 —
4 Insider transaction Mar 27, 2026 Mar 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
144 Notice of proposed sale Mar 25, 2026 —
8-K Current report
Other events
Mar 25, 2026 Mar 25, 2026
4 Insider transaction Mar 24, 2026 Mar 20, 2026
4 Insider transaction Mar 24, 2026 Mar 20, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 4, 2026 —
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
10-K Annual report Feb 24, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 24, 2026 Feb 24, 2026
8-K Current report
Other events
Feb 19, 2026 Feb 19, 2026
4 Insider transaction Feb 13, 2026 Jan 8, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2026 —
4 Insider transaction Feb 11, 2026 Feb 9, 2026
4 Insider transaction Feb 5, 2026 Feb 3, 2026
144 Notice of proposed sale Feb 3, 2026 —
4 Insider transaction Jan 29, 2026 Jan 27, 2026
8-K Current report
Other events
Jan 22, 2026 Jan 22, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
144 Notice of proposed sale Jan 6, 2026 —
4 Insider transaction Jan 5, 2026 Jan 1, 2026
8-K Current report
Other events
Dec 31, 2025 Dec 31, 2025
4 Insider transaction Dec 29, 2025 Dec 24, 2025
4 Insider transaction Dec 29, 2025 Dec 24, 2025
4 Insider transaction Dec 16, 2025 Dec 12, 2025
UPLOAD Letter from the SEC Dec 11, 2025 —
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4/A Filing Dec 3, 2025 Nov 17, 2025
144 Notice of proposed sale Dec 2, 2025 —
144 Notice of proposed sale Dec 1, 2025 —
144 Notice of proposed sale Dec 1, 2025 —
144 Notice of proposed sale Dec 1, 2025 —
4 Insider transaction Nov 26, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 7, 2025 Nov 5, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 5, 2025 —
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2025 Nov 4, 2025
144 Notice of proposed sale Nov 3, 2025 —
144 Notice of proposed sale Nov 3, 2025 —
144 Notice of proposed sale Nov 3, 2025 —
4 Insider transaction Oct 15, 2025 Oct 10, 2025
8-K Current report
Agreement ended
Oct 14, 2025 Oct 10, 2025
144 Notice of proposed sale Oct 10, 2025 —
4 Insider transaction Oct 9, 2025 Oct 7, 2025
144 Notice of proposed sale Oct 7, 2025 —
8-K Current report
Officer or director change
Oct 6, 2025 Oct 6, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
CORRESP Letter to the SEC Oct 1, 2025 —
144 Notice of proposed sale Oct 1, 2025 —
144 Notice of proposed sale Oct 1, 2025 —
144 Notice of proposed sale Oct 1, 2025 —
4 Insider transaction Sep 23, 2025 Sep 19, 2025
UPLOAD Letter from the SEC Sep 18, 2025 —
4 Insider transaction Sep 11, 2025 Sep 10, 2025
4 Insider transaction Sep 11, 2025 Sep 10, 2025
144 Notice of proposed sale Sep 10, 2025 —
8-K Current report
Other events
Sep 10, 2025 Sep 10, 2025
4 Insider transaction Sep 8, 2025 Sep 4, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
4 Insider transaction Sep 4, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 2, 2025 —
144 Notice of proposed sale Sep 2, 2025 —
144 Notice of proposed sale Sep 2, 2025 —
144 Notice of proposed sale Sep 2, 2025 —
4 Insider transaction Aug 26, 2025 Aug 22, 2025
144 Notice of proposed sale Aug 22, 2025 —
4 Insider transaction Aug 12, 2025 Aug 11, 2025
4 Insider transaction Aug 12, 2025 Aug 8, 2025

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CORT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Redwood City, CA
SEC filer status
Large accelerated filer
SEC CIK
1088856

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.